STOPTOBER – firing up the nation’s stop smoking challenge

Bzi_ris_glb_ve_1148_hi

On the 8 September Public Health England launched its latest Stoptober campaign aimed at encouraging people across the country to stop smoking from the 1 October for 28 days (and beyond). Evidence shows that if a smoker can stop for 28 days they are five times more likely to stay smoke-free. The campaign is supported by local NHS Stop Smoking Services, Local Authorities, pharmacies, retailers and large employers. This support is backed by a national TV, radio, press and online campaign running for 6 weeks. So most people are likely to have heard about it – but what’s the evidence base, how does it work and why is it necessary?

Posted on 16/10/2014 | 0 Comments

Dying well matters

Frail older people

In England, at least £4.5 billion a year is spent caring for people who are at the end-of-life, and while some individuals, particularly those accessing hospice or specialist community and hospital palliative services, receive high standards of care many others do not. Our report, Transforming care at the end-of-life, argues that while there has been a great deal of positive activity following the Department of Health’s 2008 End-of-life Care Strategy, there are still too many inequalities in access to support and availability of good quality care.

Posted on 8/10/2014 | 0 Comments

Can technology revolutionise how we deal with mental health?

Bzi_foc_glb_ho_1893

Mental health is regularly referred to as the ‘Cinderella of all NHS Cinderella services’. In recognition of this, the coalition Government’s 2011 outcomes strategy No Health Without Mental Health, set out plans to improve people’s mental health and wellbeing.

Posted on 2/10/2014 | 0 Comments

The rise of life science strategic alliances – are you ready to maximise the opportunities?

Rec_glb_ve_064_hi

This week the Center for Health Solutions is delighted to bring you a guest blog from one of our consultants in health care and life sciences: 

The life science industry is facing significant challenges such as patent cliffs, pricing and market access restrictions as well as increasing regulatory pressure. These challenges fundamentally call into question traditional business models and, as a result, life science companies are increasingly looking to new and innovative ways to tackle these challenges

Posted on 25/09/2014 | 0 Comments

Dementia: The time to act is now

Ind_tmt_glb_ho_1344_hi

In 2007, the National Audit Office’s (NAO) report “Improving services and support for people with dementia” drew Parliament’s attention to the fact that dementia presented a significant and urgent challenge to health and social care in terms of the numbers of people affected (at least 560,000 people in England) and the costs (some £14.3 billion a year, including direct costs to the NHS and social care of £3.3 billion a year). New figures out this month suggest that the challenge is even bigger.

Posted on 17/09/2014 | 0 Comments

Quality and cost: Can the NHS ever balance the duel challenge?

Bzi_ris_glb_ho_1925

The 2013-14 financial year ended with around a quarter of NHS trusts and foundation trusts in deficit[i]. While surplus cash and carry-overs helped to plug some overspends, the NHS, in aggregate spent £165 million over plan. Without some form of redress, budget pressures and increasingly unrealistic saving targets are expected to push NHS hospitals to breaking point in the next few years. 

 

Posted on 4/09/2014 | 0 Comments

My Take: An M&A roadmap to enhance the chances of success

Bzi_cho_glb_ho_1998

As mergers and acquisitions (M&A) in life sciences continue to make news headlines across the globe, we thought it would be interesting to share insights on this topical issue from Deloitte's U.S. Center for Health Solutions. This “My Take” from the August 19, 2014 Health Care Current written by Homi Kapadia, Vice Chairman, U.S Life Sciences Leader, Deloitte LLP, provides a road map of key questions that might be considered by companies seeking to transform their business through acquisitions, divestitures, or joint ventures. It also poses the question, "What will Congress do?” to pass legislation that makes these kinds of deals less attractive and encourage firms to stay in the U.S.[i]

Posted on 28/08/2014 | 0 Comments

A tale of two systems

Ind_lsh_glb_ho_1383_hi

Knee replacements are the most common joint replacement operation in Britain, with 90,000 performed each year. A few months ago I had a total knee replacement (TKR) operation in an attempt to relieve the pain and improve mobility of the joint, which had become seriously arthritic following a hockey injury several years ago.

Posted on 20/08/2014 | 0 Comments

Lyme disease - Small bite, big threat

Env_glb_ho_1747_hi

The theme of the World Health Day in April 2014 was vector-borne diseases- ‘Small Bite: Big Threat’. For many people this conjured up thoughts of Malaria, Dengue or West Nile Virus but, few people in the UK are aware that the UK’s most common vector-borne human infection is Lyme disease.[i]

Posted on 14/08/2014 | 0 Comments